
    
      This prospective, non-comparative, multi-center, post-market trial will evaluate the safety
      and efficacy of the PEEK-OPTIMAâ„¢ HA Enhance Interbody Cages System - EVOS- HA in patients
      suffering from degenerative disc disease and spondylolisthesis in the lumbar spine. The trial
      will capture clinical outcomes, radiographic and CT outcomes over a 24 month period post
      operatively. Two centers will be involved in the recruitment of 30 patients. All patients
      will be drawn from clinics which focus on this type of treatment.
    
  